Evidence map›Paper›PMID 22792362›Full record

ArticlePloS one2012

Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts.

Jin Hee Park, Pramod Darvin, Eun Joung Lim, Youn Hee Joung, Dae Young Hong, Eui U Park, Seung Hwa Park, Soo Keun Choi, Eon-Soo Moon, Byung Wook Cho and 6 more

4 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01670955 phase2completednot on this map

A Prospective Phase II/III Randomized, Blinded Study to Demonstrate the Safety and Effectiveness of Jobelyn ( a Herbal Preparation ) in Pre-operative Management of Anaemia in Gynaecological Patients

TypeinterventionalSponsorLagos State UniversityRan2012 to 2013Enrolled73ConditionsAnemiaArmsJobelyn, Ferrous Sulphate + Folic Acid
NCT01703104 phase1 / phase2completednot on this map

The Effect of Jobelyn ( Extract of Sorghum Bicolor) on the Haematological Parameters of Patients With Sickle Cell Anaemia Disease.

TypeinterventionalSponsorLagos State UniversityRan2012 to 2012Enrolled150ConditionsSickle Cell AnemiaArmsPaludrine + Folic Acid, Paludrine + Folic Acid + Jobelyn
NCT01704794 phase1 / phase2unknown statusnot on this mapstarted 2013, after this paper: background citation

Antioxidant Effect of the Extract of Jobelyn (Sorghum Bicolor) on the Quality of Life of Patients With Sickle Cell Disease

TypeinterventionalSponsorLagos State UniversityRan2013 to 2014Enrolled96ConditionsOther Sickle-cell Disorders With Crisis, UnspecifiedArmsFolic Acid + Paludrine + Jobelyn (500mg), Folic Acid + Paludrine + Jobelyn (250mg), Folic Acid + Paludrine + Jobelyn (2mg)
NCT01936064 phase1 / phase2unknown statusnot on this mapstarted 2016, after this paper: background citation

A Prospective Phase II Randomized, Blinded Study to Demonstrate the Effectiveness of Jobelyn for the Treatment of Breast Cancer Patients.

TypeinterventionalSponsorLagos State UniversityRan2016 to 2018Enrolled60ConditionsHaematological AbnormalityArmsJobelyn + Cyclophosphamide-Epirubicin6, Placebo + Cyclophosphamide - Epirubicin 6
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 120 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Targeting protein tyrosine kinase 6 in cancer.Biochimica et biophysica acta. Reviews on cancer · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Jin Hee ParkDepartment of Pathology, School of Medicine, and Institute of Biomedical Science and Technology, Konkuk University Glocal Campus, Seoul, South Korea.
Pramod Darvin
Eun Joung Lim
Youn Hee Joung
Dae Young Hong
Eui U Park
Seung Hwa Park
Soo Keun Choi
Eon-Soo Moon
Byung Wook Cho
Kyung Do Park
Hak Kyo Lee
Myong-Jo Kim
Dong-Sik Park
Ill-Min Chung
Young Mok Yang
Konkuk University · KRHankyong National University · KRKangwon National University · KRKonkuk University Medical Center · KRKyung Hee University · KRPusan National University · KRRural Development Administration · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer is one of the highly virulent diseases known to humankind with a high mortality rate. Breast cancer is the most common cancer in women worldwide. Sorghum is a principal cereal food in many parts of the world, and is critical in folk medicine of Asia and Africa. In the present study, we analyzed the effects of HSE in metastatic breast cancer. METHODOLOGY/PRINCIPAL

findingsPreliminary studies conducted on MDA-MB 231 and MCF-7 xenograft models showed tumor growth suppression by HSE. Western blotting studies conducted both in vivo and in vitro to check the effect of HSE in Jak/STAT pathways. Anti-metastatic effects of HSE were confirmed using both MDA-MB 231 and MCF-7 metastatic animal models. These studies showed that HSE can modulate Jak/STAT pathways, and it hindered the STAT5b/IGF-1R and STAT3/VEGF pathways not only by down-regulating the expression of these signal molecules and but also by preventing their phosphorylation. The expression of angiogenic factors like VEGF, VEGF-R2 and cell cycle regulators like cyclin D, cyclin E, and pRb were found down-regulated by HSE. In addition, it also targets Brk, p53, and HIF-1α for anti-cancer effects. HSE induced G1 phase arrest and migration inhibition in MDA-MB 231 cells. The metastasis of breast cancer to the lungs also found blocked by HSE in the metastatic animal model. CONCLUSIONS/SIGNIFICANCE: Usage of HS as a dietary supplement is an inexpensive natural cancer therapy, without any side effects. We strongly recommend the use of HS as an edible therapeutic agent as it possesses tumor suppression, migration inhibition, and anti-metastatic effects on breast cancer.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicBreast NeoplasmsCell ProliferationDose-Response Relationship, DrugFemaleG1 Phase Cell Cycle CheckpointsGene Expression Regulation, NeoplasticHumansHypoxia-Inducible Factor 1, alpha SubunitJanus Kinase 2Lung NeoplasmsMCF-7 CellsMiceMice, NudeNeoplasm MetastasisAntineoplastic Agents, PhytogenicHypoxia-Inducible Factor 1, alpha SubunitJanus Kinase 2Oncogene ProteinsPlant ExtractsReceptor, IGF Type 1STAT3 Transcription FactorSTAT5 Transcription FactorSTAT Transcription FactorsTumor Suppressor ProteinsVascular Endothelial Growth Factor A

Identifiers

PMID22792362
PMCPMC3391253
OpenAlexW2034986953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.